Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...
Streetwise Reports | August 14, 2019 |

BioNTech, CureVac, or Valeo Pharma: who brings the highest return to shareholders?

When the Corona Pandemic started in November 2019 in Wuhan, China, nobody could have guessed the extent of the disease. Socially, economically and politically, Covid-19 has turned the world upside down. With increasing knowledge in dealing with the Corona Virus, people around ...
Mario Hose | September 23, 2020 |

Valeo Pharma, CureVac, Moderna, Sartorius: high-flyers or latecomers?

The pandemic continues to spread: Germany is now facing a complete lockdown. Meanwhile, there is good news from the vaccine and drug manufacturers. There are several vaccines available, and from 2021 onwards, vaccination programs are to be implemented rapidly in all industrial...
Nico Popp | December 9, 2020 |

Buzz on the Bullboards: Today’s gainers and tomorrow’s winners

Investors dealt with another rate increase from the U.S. Federal Reserve, but could it be the finale for awhile? Time will tell, but many hope this, the 10th straight rate increase reaching its highest point in 16 years, will be enough to help calm unreasonably high ...
Jonathon Brown | May 4, 2023 |

Meet the Fresh, New Face of the Booming Plant-based Economy

(Click image to play video) Stockhouse investors and readers know the plant-based economy is booming. And they also know that while opportunities abound, not all of these companies are created equal. But one, uniquely-positioned West Vancouver, BC-based company ...
Dave Jackson | January 29, 2021 |

Online Gaming Company Values Experience After Moving to Senior Exchange

(Click image to play video) Never has the world of online gaming been bigger or more competitive. Access to gaming is opening up around the world. The number of online console gamers eclipsed 57 million in the United States last year and the market for PC on...
Simon Druker | February 18, 2021 |

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million

The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. In an April 30 research note, analyst Joseph Pantginis reported that Oxford Biomedica Plc ...
Streetwise Reports | May 9, 2019 |

Three More Years of Expansion? How Will Gold React?

We are just a few weeks from breaking the record. If the current US economic expansion lasts until July 2019, it will reach 121 months, becoming the longest ever. The extended duration of the prosperity begs the question of when the next downturn will occur. We invite you to r...
Arkadiusz Sieron | May 27, 2019 |

Canadian Gold Miner Achieves 'Strong Q3/19 Operationally'

The company's performance during the quarter is covered in a Haywood report. In a Nov. 1 research note, Haywood analyst Kerry Smith reported that Equinox Gold Corp. (EQX:TSX.V) , in its first quarter of commercial production at the Aurizona mine, "delivered a solid Q...
Streetwise Reports | November 22, 2019 |

Biopharma 'Keeps Executing and Securing Milestones'

The company's latest achievement and partnership potential are addressed in a ROTH Capital Partners report. In a Dec. 12 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) received U.S. Food and Drug Adminis...
Streetwise Reports | December 19, 2019 |
1 2 3 4 5